Novel transcript, antisense to dystrobrevin-binding protein 1 (ENSG00000307291)

ENSG00000307291 corresponds to a "novel transcript, antisense to DTNBP1". This is not a well-characterized protein-coding gene, receptor, enzyme, or any established therapeutic target. Its main feature is that it is an antisense transcript relative to the dystrobrevin-binding protein 1 (DTNBP1) gene; antisense transcripts are typically non-coding RNAs transcribed from the DNA strand opposite to the "sense" (protein-coding) gene. They may play regulatory roles but are generally not direct targets for drugs, diagnostics, or therapeutic intervention in the way proteins, enzymes, or receptors are. There is no established abbreviation, therapeutic relevance, biological function, molecular classification, disease linkage, interacting drugs, mechanism of action, or biomarkers for this entity in the current biomedical literature. Note: - This record is likely a predicted transcript from genomic annotation (e.g., Ensembl), not a validated or well-studied target. - DTNBP1 (dystrobrevin-binding protein 1, or dysbindin) itself is a well-studied gene implicated in synaptic function and certain neuropsychiatric conditions, but the antisense transcript has no confirmed function or pharmacological relevance[1][2][5]. - If you meant to refer to DTNBP1 (dysbindin), see those entries for extensive functional and disease-association data. - If your focus is on the antisense transcript, available knowledge is currently very limited—there is no evidence for it being a therapeutic target or having characterized biological functions.

Other names

Novel transcript antisense to DTNBP1